Tinavi Total Liab vs Common Stock Shares Outstanding Analysis

688277 Stock

10.66 0.08 0.74%

Tinavi Medical financial indicator trend analysis is much more than just breaking down Tinavi Medical Techn prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Tinavi Medical Techn is a good investment. Please check the relationship between Tinavi Medical Total Liab and its Common Stock Shares Outstanding accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Tinavi Medical Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Total Liab vs Common Stock Shares Outstanding

Total Liab vs Common Stock Shares Outstanding Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Tinavi Medical Techn Total Liab account and Common Stock Shares Outstanding. At this time, the significance of the direction appears to have strong contrarian relationship.

The correlation between Tinavi Medical's Total Liab and Common Stock Shares Outstanding is -0.66. Overlapping area represents the amount of variation of Total Liab that can explain the historical movement of Common Stock Shares Outstanding in the same time period over historical financial statements of Tinavi Medical Technologies, assuming nothing else is changed. The correlation between historical values of Tinavi Medical's Total Liab and Common Stock Shares Outstanding is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Liab of Tinavi Medical Technologies are associated (or correlated) with its Common Stock Shares Outstanding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Common Stock Shares Outstanding has no effect on the direction of Total Liab i.e., Tinavi Medical's Total Liab and Common Stock Shares Outstanding go up and down completely randomly.

Correlation Coefficient

-0.66

Relationship Direction	Negative
Relationship Strength	Weak

View All Relationships

Total Liab

The total amount of all liabilities that a company has, including both short-term and long-term liabilities.

Common Stock Shares Outstanding

The total number of shares of a company's common stock that are currently owned by all its shareholders.

Most indicators from Tinavi Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Tinavi Medical Techn current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Tinavi Medical Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

The current year's Tax Provision is expected to grow to about 11.1 M, whereas Selling General Administrative is forecasted to decline to about 105.6 M.

	2021	2022	2023	2024 (projected)
Gross Profit	106.1M	102.6M	149.4M	126.3M
Total Revenue	156.0M	156.2M	210.0M	170.9M

Gross Profit Total Revenue

Tinavi Medical fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Deferred Long Term Liab	Net Invested Capital	Total Current Assets	Non Current Liabilities Other	Net Working Capital	Intangible Assets	Common Stock
Total Assets		-0.8	-0.68	0.95	0.83	0.92	-0.9	0.76	-0.56	0.98	0.58	0.94	0.21	0.9	0.83	0.77	0.83	0.92	-0.38	0.85	0.96	-0.38	0.84	0.47	0.86	0.91
Other Current Liab	-0.8		0.98	-0.94	-0.59	-0.95	0.72	-0.6	0.85	-0.77	-0.5	-0.78	-0.55	-0.91	-0.63	-0.94	-0.83	-0.77	0.83	-0.88	-0.92	0.32	-0.89	-0.79	-0.75	-0.9
Total Current Liabilities	-0.68	0.98		-0.88	-0.42	-0.9	0.57	-0.43	0.82	-0.63	-0.5	-0.65	-0.56	-0.86	-0.47	-0.92	-0.72	-0.64	0.93	-0.78	-0.84	0.17	-0.86	-0.88	-0.63	-0.84
Total Stockholder Equity	0.95	-0.94	-0.88		0.7	0.99	-0.82	0.66	-0.69	0.9	0.6	0.89	0.36	0.96	0.73	0.89	0.84	0.86	-0.65	0.87	1.0	-0.28	0.92	0.71	0.82	0.96
Other Liab	0.83	-0.59	-0.42	0.7		0.65	-0.92	0.87	-0.56	0.87	0.43	0.94	0.15	0.7	0.95	0.57	0.81	0.96	-0.08	0.87	0.73	-0.71	0.65	0.12	0.86	0.68
Net Tangible Assets	0.92	-0.95	-0.9	0.99	0.65		-0.76	0.59	-0.69	0.87	0.64	0.85	0.35	0.96	0.66	0.91	0.8	0.82	-0.71	0.84	0.98	-0.21	0.93	0.76	0.78	0.96
Retained Earnings	-0.9	0.72	0.57	-0.82	-0.92	-0.76		-0.96	0.58	-0.89	-0.28	-0.95	-0.26	-0.78	-0.98	-0.63	-0.95	-0.95	0.23	-0.89	-0.85	0.56	-0.72	-0.33	-0.97	-0.77
Accounts Payable	0.76	-0.6	-0.43	0.66	0.87	0.59	-0.96		-0.52	0.77	0.06	0.85	0.28	0.6	0.97	0.47	0.9	0.87	-0.1	0.82	0.71	-0.63	0.52	0.18	0.92	0.58
Cash	-0.56	0.85	0.82	-0.69	-0.56	-0.69	0.58	-0.52		-0.63	-0.35	-0.62	-0.74	-0.72	-0.55	-0.82	-0.72	-0.67	0.69	-0.85	-0.68	0.63	-0.73	-0.48	-0.55	-0.7
Non Current Assets Total	0.98	-0.77	-0.63	0.9	0.87	0.87	-0.89	0.77	-0.63		0.58	0.93	0.28	0.86	0.84	0.75	0.81	0.93	-0.31	0.88	0.93	-0.55	0.79	0.34	0.81	0.87
Non Currrent Assets Other	0.58	-0.5	-0.5	0.6	0.43	0.64	-0.28	0.06	-0.35	0.58		0.55	-0.14	0.6	0.23	0.69	0.19	0.52	-0.42	0.46	0.55	-0.15	0.58	0.37	0.24	0.6
Other Assets	0.94	-0.78	-0.65	0.89	0.94	0.85	-0.95	0.85	-0.62	0.93	0.55		0.18	0.85	0.93	0.76	0.88	0.99	-0.34	0.92	0.9	-0.54	0.79	0.41	0.92	0.83
Net Receivables	0.21	-0.55	-0.56	0.36	0.15	0.35	-0.26	0.28	-0.74	0.28	-0.14	0.18		0.33	0.24	0.35	0.44	0.25	-0.5	0.52	0.38	-0.39	0.38	0.32	0.27	0.36
Common Stock Shares Outstanding	0.9	-0.91	-0.86	0.96	0.7	0.96	-0.78	0.6	-0.72	0.86	0.6	0.85	0.33		0.69	0.9	0.84	0.81	-0.66	0.84	0.95	-0.26	0.99	0.7	0.79	0.99
Non Current Liabilities Total	0.83	-0.63	-0.47	0.73	0.95	0.66	-0.98	0.97	-0.55	0.84	0.23	0.93	0.24	0.69		0.54	0.91	0.94	-0.13	0.88	0.76	-0.64	0.63	0.21	0.95	0.67
Inventory	0.77	-0.94	-0.92	0.89	0.57	0.91	-0.63	0.47	-0.82	0.75	0.69	0.76	0.35	0.9	0.54		0.7	0.74	-0.8	0.81	0.85	-0.34	0.86	0.72	0.61	0.87
Other Current Assets	0.83	-0.83	-0.72	0.84	0.81	0.8	-0.95	0.9	-0.72	0.81	0.19	0.88	0.44	0.84	0.91	0.7		0.88	-0.44	0.9	0.86	-0.49	0.8	0.51	0.95	0.82
Other Stockholder Equity	0.92	-0.77	-0.64	0.86	0.96	0.82	-0.95	0.87	-0.67	0.93	0.52	0.99	0.25	0.81	0.94	0.74	0.88		-0.32	0.95	0.87	-0.63	0.76	0.35	0.91	0.8
Total Liab	-0.38	0.83	0.93	-0.65	-0.08	-0.71	0.23	-0.1	0.69	-0.31	-0.42	-0.34	-0.5	-0.66	-0.13	-0.8	-0.44	-0.32		-0.51	-0.6	-0.08	-0.68	-0.92	-0.33	-0.63
Deferred Long Term Liab	0.85	-0.88	-0.78	0.87	0.87	0.84	-0.89	0.82	-0.85	0.88	0.46	0.92	0.52	0.84	0.88	0.81	0.9	0.95	-0.51		0.88	-0.66	0.81	0.46	0.87	0.82
Net Invested Capital	0.96	-0.92	-0.84	1.0	0.73	0.98	-0.85	0.71	-0.68	0.93	0.55	0.9	0.38	0.95	0.76	0.85	0.86	0.87	-0.6	0.88		-0.3	0.91	0.66	0.85	0.96
Total Current Assets	-0.38	0.32	0.17	-0.28	-0.71	-0.21	0.56	-0.63	0.63	-0.55	-0.15	-0.54	-0.39	-0.26	-0.64	-0.34	-0.49	-0.63	-0.08	-0.66	-0.3		-0.2	0.3	-0.4	-0.24
Non Current Liabilities Other	0.84	-0.89	-0.86	0.92	0.65	0.93	-0.72	0.52	-0.73	0.79	0.58	0.79	0.38	0.99	0.63	0.86	0.8	0.76	-0.68	0.81	0.91	-0.2		0.73	0.75	0.98
Net Working Capital	0.47	-0.79	-0.88	0.71	0.12	0.76	-0.33	0.18	-0.48	0.34	0.37	0.41	0.32	0.7	0.21	0.72	0.51	0.35	-0.92	0.46	0.66	0.3	0.73		0.48	0.68
Intangible Assets	0.86	-0.75	-0.63	0.82	0.86	0.78	-0.97	0.92	-0.55	0.81	0.24	0.92	0.27	0.79	0.95	0.61	0.95	0.91	-0.33	0.87	0.85	-0.4	0.75	0.48		0.77
Common Stock	0.91	-0.9	-0.84	0.96	0.68	0.96	-0.77	0.58	-0.7	0.87	0.6	0.83	0.36	0.99	0.67	0.87	0.82	0.8	-0.63	0.82	0.96	-0.24	0.98	0.68	0.77

Click cells to compare fundamentals

Tinavi Medical Account Relationship Matchups

Tinavi Medical fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	713.6M	1.1B	1.3B	1.4B	1.6B	1.2B
Other Current Liab	50.0M	47.1M	43.2M	1.2M	526.7K	500.4K
Total Current Liabilities	96.3M	80.6M	113.2M	158.4M	167.0M	130.7M
Total Stockholder Equity	585.3M	996.0M	1.0B	1.0B	1.2B	876.7M
Other Liab	7.9M	20.9M	12.2M	50.1M	57.6M	60.5M
Net Tangible Assets	582.6M	989.8M	999.3M	918.2M	1.1B	769.4M
Retained Earnings	(69.1M)	(117.2M)	(192.1M)	(310.8M)	(467.2M)	(443.9M)
Accounts Payable	4.2M	4.0M	9.6M	28.5M	44.1M	46.3M
Cash	152.6M	468.4M	287.1M	211.4M	310.9M	250.2M
Non Current Assets Total	186.0M	325.0M	771.6M	1.0B	1.1B	567.8M
Non Currrent Assets Other	3.6M	116.5M	308.6M	175.0M	6.6M	6.3M
Other Assets	23.4M	36.0M	153.4M	386.5M	444.4M	466.6M
Net Receivables	53.7M	15.9M	27.3M	28.7M	46.6M	28.2M
Common Stock Shares Outstanding	188.3M	376.5M	418.4M	419.8M	449.4M	381.9M
Non Current Liabilities Total	20.9M	12.2M	98.3M	131.0M	214.9M	225.7M
Inventory	32.1M	34.8M	37.9M	43.8M	26.2M	34.1M
Other Current Assets	16.5M	12.9M	11.0M	20.8M	32.7M	34.4M
Total Liab	117.3M	92.7M	211.5M	289.4M	382.0M	259.0M
Deferred Long Term Liab	11.4M	13.4M	4.8M	20.2M	23.3M	24.4M
Net Invested Capital	585.3M	996.0M	1.0B	1.1B	1.5B	923.3M
Total Current Assets	527.6M	794.3M	507.4M	373.4M	488.8M	435.5M
Non Current Liabilities Other	6.4M	6.2M	6.8M	5.2M	6.9M	5.4M
Net Working Capital	431.3M	713.8M	394.2M	215.0M	321.8M	419.1M
Intangible Assets	2.7M	6.3M	7.6M	6.7M	17.2M	18.1M
Common Stock	188.3M	376.5M	418.4M	419.8M	482.8M	343.5M
Property Plant Equipment	21.3M	20.1M	24.4M	112.3M	129.2M	135.7M

Currently Active Assets on Macroaxis

C	Citigroup
GM	General Motors
F	Ford Motor
GM	General Motors
V	Visa Class A

Other Information on Investing in Tinavi Stock

Balance Sheet is a snapshot of the financial position of Tinavi Medical Techn at a specified time, usually calculated after every quarter, six months, or one year. Tinavi Medical Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Tinavi Medical and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Tinavi currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Tinavi Total Liab vs Common Stock Shares Outstanding Analysis

Total Liab vs Common Stock Shares Outstanding

Total Liab vs Common Stock Shares Outstanding Correlation Analysis

Correlation Coefficient

Total Liab

Common Stock Shares Outstanding

Tinavi Medical fundamental ratios Correlations

Tinavi Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Tinavi Medical fundamental ratios Accounts

Currently Active Assets on Macroaxis

Other Information on Investing in Tinavi Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Invested Capital	+ 1.0	Total Stockholder Equity
Net Tangible Assets	+ 0.99	Total Stockholder Equity
Other Stockholder Equity	+ 0.99	Other Assets
Non Current Liabilities Other	+ 0.99	Common Stock Shares Outstanding
Common Stock	+ 0.99	Common Stock Shares Outstanding
Non Current Assets Total	+ 0.98	Total Assets

Non Current Liabilities Total	- 0.98	Retained Earnings
Intangible Assets	- 0.97	Retained Earnings
Accounts Payable	- 0.96	Retained Earnings
Other Stockholder Equity	- 0.95	Retained Earnings
Other Current Assets	- 0.95	Retained Earnings
Other Assets	- 0.95	Retained Earnings